Silodosin

CAS 160970-54-7 15 current records 1 historicalSmall Molecule

Who holds supplier records for Silodosin? 15 organisations hold a current record for Silodosin: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: India (9), China (2), Japan (1), Italy (1) and 1 other country (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Silodosin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/silodosin

Reading the evidence

  • 15 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    9 of the 14 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 9 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (15)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Silodosin. Country is the organisation's recorded country, not necessarily the manufacturing site.

India9China2Japan1Italy1United Kingdom1Country not recorded for 1
Need Silodosin sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (1)

Organisations whose Type II DMFs for Silodosin are no longer active. These show a past filing, not current supply.

Show all 1 historical record

Overview

Silodosin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL24778).

Chemical identity

IUPAC name
1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]-2,3-dihydroindole-7-carboxamide
Canonical SMILES
C[C@H](CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F
InChIKey
PNCPYILNMDWPEY-QGZVFWFLSA-N
Synonyms
KAD-3213, KMD-3213, Kso-0400, Rapaflo, Rapilif, Silodal, Silodosin, Silodosina, Silodosine, Silodosin recordati, Silodyx, Urief

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
alpha-Adrenergic Blocker
Mechanism of action
Adrenergic alpha-Antagonists

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Silodosin?

15 organisations hold an active US FDA Type II Drug Master File or a CEP for Silodosin: Alembic Pharmaceuticals Limited (India), ALP PHARM BEIJING CO LTD, APITORIA PHARMA PRIVATE LTD (India), Hetero Drugs Limited (India), Kissei Pharmaceutical Co., Ltd. (Japan), Macleods Pharmaceuticals Ltd. (India), METROCHEM API PRIVATE LTD (India) and MSN Laboratories Private Limited (India), and 7 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Silodosin Drug Master Files are active?

Alembic Pharmaceuticals Limited (DMF 29659), ALP PHARM BEIJING CO LTD (DMF 27082), APITORIA PHARMA PRIVATE LTD (DMF 31316), Hetero Drugs Limited (DMF 26423), Kissei Pharmaceutical Co., Ltd. (DMF 13030), Macleods Pharmaceuticals Ltd. (DMF 31359), METROCHEM API PRIVATE LTD (DMF 34538) and MSN Laboratories Private Limited (DMF 26957) and 7 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Silodosin records mean?

1 organisation has only inactive Type II DMFs for Silodosin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Silodosin supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Silodosin?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.